We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abraxis BioScience and The Scripps Research Institute Enter Exclusive Licensing Agreement

News   Aug 23, 2007

 
Abraxis BioScience and The Scripps Research Institute Enter Exclusive Licensing Agreement
 
 
 

RELATED ARTICLES

HPV-Positive Throat Cancer Patients Should Keep Taking Chemotherapy

News

Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug during curative radiotherapy, new clinical trial results have shown.

READ MORE

Scorpion Venom Can Shuttle Drugs into the Brain

News

Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain.

READ MORE

Biopatch Delivers Exact Drug Doses Directly into Cells

News

Minimally invasive patch developed by Purdue researchers delivers exact doses directly into cells, lessens pain and toxicity.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE